Dr. Pamela W Linnell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1210 N Main St Ste 304, Roswell, NM 88201 Phone: 505-622-4519 Fax: 505-623-3232 |
John Draper, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 110 E Mescalero Rd, Roswell, NM 88201 Phone: 505-623-1480 Fax: 505-622-3325 |
Steven M Cobb, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 400 N Pennsylvania Ave, Suite 990-b, Roswell, NM 88201 Phone: 575-622-6437 Fax: 575-622-3037 |
Brian Keith Whitlock, PH.D. Psychologist - Health Service Medicare: Not Enrolled in Medicare Practice Location: 601 W 2nd St, Suite 10, Roswell, NM 88201 Phone: 575-623-9322 Fax: 575-627-6339 |
Dr. Thomas De Vries, PH.D Psychologist - Prescribing (Medical) Medicare: Not Enrolled in Medicare Practice Location: 405 W Coutry Club Rd, Roswell, NM 88201 Phone: 505-273-0574 |
Karen Haughness, LPCC., PH.D. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 300 N Kentucky Ave, Roswell, NM 88201 Phone: 505-627-2602 Fax: 505-627-2544 |
Dr. Lynn B Daugherty, PH. D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 200 W 1st St, Suite 323, Roswell, NM 88203 Phone: 505-623-1943 |
News Archive
Three stakeholder groups agree that regulators are not adequately prepared to manage the risks posed by nanotechnology, according to a paper published in the peer-reviewed journal PLOS One. In a survey of nano-scientists and engineers, nano-environmental health and safety scientists, and regulators, researchers at the UCSB Center for Nanotechnology in Society (CNS) and at the University of British Columbia found that those who perceive the risks posed by nanotechnology as "novel" are more likely to believe that regulators are unprepared.
New research shows that for some women, a high-protein meal followed by 30 minutes of moderate exercise is an effective way of burning calories, especially when compared to exercising on an empty stomach.
Flamel Technologies today announced that Pfizer (NYSE:PFE) has exercised its option to license Flamel's Medusa® technology for the development of a controlled release formulation of an already-marketed therapeutic protein.
The electronic nose is a newer version of a sensor that has been used in the food, wine and perfume industries. It is also being used as an aid against terrorism, to sniff out explosives or toxic chemicals in the air.
› Verified 5 days ago